NCT00255086View on ClinicalTrials.gov

The Effect of Memantine on Brain Structure and Chemistry in Alzheimer's Disease Patients

PHASE3CompletedINTERVENTIONAL

Enrollment

17

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

June 30, 2009

Study Completion Date

February 28, 2010

Conditions

Alzheimer Disease

Interventions

DRUG

Memantine

10mg Memantine

DRUG

Placebo pill

10mg placebo pill

Trial Locations (1)

94304

VA Palo Alto Health Care System, Palo Alto

Sponsors

Collaborators (1)

Forest Laboratories

All Listed Sponsors

collaborator

Palo Alto Veterans Institute for Research

OTHER

collaborator

Forest Laboratories

INDUSTRY

lead

Stanford University

OTHER